How many email patterns does Anokion use?

Anokion uses 5 known email patterns.

What domain does Anokion use for work emails?

Anokion uses anokion.com for work email addresses.

Most Common Email Formats at Anokion

Anokion's most common email format is First.Last@anokion.com (ex. John.Doe@anokion.com), used for 92% of anokion.com addresses. Anokion uses 4 email patterns.

@anokion.com

4 patterns

Format	Example	Share of anokion.com
First.Last@anokion.comMost common	John.Doe@anokion.com	92%
Last.First@anokion.com	Doe.John@anokion.com	4%
First_Last@anokion.com	John_Doe@anokion.com	2%
First@anokion.com	John@anokion.com	2%

Need a specific person's email?

Browse Anokion's employee directory (about 14 employees) and reveal verified emails free.

Frequently Asked Questions

What does Anokion do?

Anokion operates in the Biotechnology Research industry, alongside similar companies like Selecta Biosciences, Codiak BioSciences and Evelo Biosciences. You can visit anokion.com. Explore Anokion's company overview page for more information.

What is Anokion's email address format?

Anokion's email format typically follows the pattern of First.Last@anokion.com; this email format is used 92% of the time. Other contacts within LeadIQ's database had email formats such as Last.First@anokion.com and First_Last@anokion.com. Looking for more contact data? Unlock accurate emails and phone numbers from millions of profiles verified in real-time.

How many employees does Anokion have currently?

Anokion has approximately 14 employees as of July 2026. Key team members to contact include Owner: C. R., Senior Director, Finance & Corporate Controller: H. B. and Director Of Finance: M. D. For more team information and contact data, explore Anokion's employee directory with LeadIQ.

Anokion Email Format

Q: What is Anokion's email address format?

Anokion's email format typically follows the pattern of ${fn}.${ln}. Other email formats include ${ln}.${fn} and ${fn}_${ln}.

Biotechnology ResearchMassachusetts, United States11-50 Employees

Anokion is a clinical-stage biotechnology company focused on autoimmune diseases, aiming to restore normal immune tolerance. Its research targets both common and rare conditions, including celiac disease, multiple sclerosis, and type 1 diabetes. The company uses an immune-based platform that engages pathways in the liver to reestablish immune tolerance and address the root causes of autoimmune dysfunction. Described as Swiss in origin, Anokion is listed at a Cambridge, Massachusetts address in the United States.

In September 2023, Anokion reported clinical progress for its KAN-101 and ANK-700 programs, signaling advancement in its therapeutic efforts. Operating within the biotechnology research sector, the company seeks to translate immune-tolerance concepts into treatments for patients affected by autoimmune diseases.

Most common format

First.Last@anokion.com

Example: John.Doe@anokion.com

4 patterns. See all formats

Verify a Anokion email address

Free with a LeadIQ account. No credit card.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

Everything for prospecting,
in one platform.

What you can expect from LeadIQ:

B2B data verified in real-time
Sync data to your CRM, & add it to an outreach sequence in one click
Integrations with your tech stack for optimal efficiency
A patented AI cold email generator
Account & contact-level job change tracking

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

Most Common Email Formats at Anokion

@anokion.com

Need a specific person's email?

Frequently Asked Questions

What does Anokion do?

What is Anokion's email address format?

How many employees does Anokion have currently?

Anokion Email Format

Ready to create more pipeline?

Everything for prospecting,in one platform.

What you can expect from LeadIQ:

Ready to create more pipeline?

Everything for prospecting,
in one platform.